Skip to main content
OpenTrials

Clinical trial condition

Hemophilia B

Explore clinical trials studying Hemophilia B. Study availability and eligibility vary by location and protocol.

205 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia B trial results

Completed

Gene Therapy for Chinese Hemophilia B

NCT04135300

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
View Trial Details
Completed

A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B

NCT03055611

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Swedish Orphan Biovitrum Reserach site Berlin, Germany
  • Swedish Orphan Biovitrum Reserach Site Blaubeuren Abbey, Germany
  • Swedish Orphan Biovitrum Research Site Bonn, Germany
  • Swedish Orphan Biovitrum Research Site Delmenhorst, Germany
View all 22 locations
View Trial Details
Completed

A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

NCT03655340

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Swedish Orphan Biovitrum Research Site (CHU de Bordeaux) Bordeaux, France
  • Swedish Orphan Biovitrum Research Site Brest, France
  • Swedish Orphan Biovitrum Research Site Caen, France
  • Swedish Orphan Biovitrum Research Site Chambéry, France
View all 18 locations
View Trial Details
Completed

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)

NCT04731701

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Swedish Orphan Biovitrum Clinical site Paris, Cochin, France
  • Swedish Orphan Biovitrum Clinical site Paris, Kremlin-Bicêtre, France
  • Swedish Orphan Biovitrum Clinical site Besançon, France
  • Swedish Orphan Biovitrum Clinical site Bordeaux, France
View all 16 locations
View Trial Details
Completed

RIXUBIS Drug Use-Result Survey (Japan)

NCT02937831

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Seki-shi, Japan Seki-shi, Gifu, Japan
  • Maebashi-shi, Japan Maebashi, Gunma, Japan
  • Nobeoka-shi, Japan Nobeoka-shi, Miyazaki, Japan
  • Niigata-shi, Japan Niigata, Japan
View Trial Details
Completed

Dose Confirmation Trial of AAV5-hFIXco-Padua

NCT03489291

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • University of California, Davis Sacramento, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Completed

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

NCT02554773

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Clinical Trial Site Ann Arbor, Michigan, United States
  • Clinical Trial Site Pittsburgh, Pennsylvania, United States
  • Clinical Trial Site Plovdiv, Bulgaria
  • Clinical Trial Site Sofia, Bulgaria
View Trial Details

Related conditions